HLAResolver: A statistical framework for resolving HLA ambiguity in T-cell response data
- 1University of Chicago
Abstract
Large-scale models of T-cell recognition require training examples that specify the complete T-cell receptor (TCR)-peptide-human leukocyte antigen (HLA) complex. Multiplexed Identification of T-cell Receptor Antigen Specificity (MIRA) is a high-throughput assay that identifies TCRs associated with responses to specific peptides, but does not determine which HLA presents each peptide. Because a donor can carry up to six distinct class I HLA-A, HLA-B, and HLA-C alleles, each response may have several candidate presenting HLAs. To narrow this set of candidate presenting HLAs, we developed HLAResolver, a statistical framework that combines MIRA response patterns across HLA-typed donors with NetMHCpan predictions of peptide presentation. For each peptide, HLAResolver uses negative-binomial regression to jointly estimate associations between HLA alleles and TCR response counts, accounting for differences in assay yield. NetMHCpan eluted-ligand predictions guide sparse regularization, favoring alleles with stronger predicted presentation while allowing strong MIRA response evidence to support alternatives. To assess whether this integration provides an advantage over either approach alone, we compared HLAResolver with NetMHCpan, which predicts peptide-HLA presentation, and the Restrictor Analysis Tool for Epitopes (RATE), which infers HLA associations from T-cell response patterns. Using held-out MIRA experiments, we assessed each method's ability to predict observed responses and the number of candidate HLAs it assigned. At matched specificity for predicting MIRA responses, HLAResolver achieved higher sensitivity while selecting fewer candidate HLAs per peptide than either comparator.
Related
- A statistical framework for system-level synthesis
- Replication-Enhanced Detection of Quantitative Traits Evolving Adaptively (REDQuanTEA): an improved statistical framework to detect locally adaptive traits
- An ensemble framework for robust drug response prediction and large-scale sensitivity profiling across cancers
- Estimating total human deaths from rabies: A statistical framework leveraging reports of rabies transmission from deceased organ and tissue donors
- SpacePath enables pathway and molecular-family analysis beyond annotation ambiguity in spatial metabolomics and lipidomics
BibTeX
@misc{alasadi2026hlaresolver,
title = {{HLAResolver: A statistical framework for resolving HLA ambiguity in T-cell response data}},
author = {H. Al-Asadi and M. T. Noakes and M. Klinger and B. Howie and H. Robins},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.29.762841},
url = {https://www.biorxiv.org/content/10.64898/2026.10.29.762841v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - HLAResolver: A statistical framework for resolving HLA ambiguity in T-cell response data
AU - H. Al-Asadi
AU - M. T. Noakes
AU - M. Klinger
AU - B. Howie
AU - H. Robins
PY - 2026
DA - 2026/10/29
PB - bioRxiv
DO - 10.64898/2026.10.29.762841
UR - https://www.biorxiv.org/content/10.64898/2026.10.29.762841v1
AB - Large-scale models of T-cell recognition require training examples that specify the complete T-cell receptor (TCR)-peptide-human leukocyte antigen (HLA) complex. Multiplexed Identification of T-cell Receptor Antigen Specificity (MIRA) is a high-throughput assay that identifies TCRs associated with responses to specific peptides, but does not determine which HLA presents each peptide. Because a donor can carry up to six distinct class I HLA-A, HLA-B, and HLA-C alleles, each response may have several candidate presenting HLAs. To narrow this set of candidate presenting HLAs, we developed HLAResolver, a statistical framework that combines MIRA response patterns across HLA-typed donors with NetMHCpan predictions of peptide presentation. For each peptide, HLAResolver uses negative-binomial regression to jointly estimate associations between HLA alleles and TCR response counts, accounting for differences in assay yield. NetMHCpan eluted-ligand predictions guide sparse regularization, favoring alleles with stronger predicted presentation while allowing strong MIRA response evidence to support alternatives. To assess whether this integration provides an advantage over either approach alone, we compared HLAResolver with NetMHCpan, which predicts peptide-HLA presentation, and the Restrictor Analysis Tool for Epitopes (RATE), which infers HLA associations from T-cell response patterns. Using held-out MIRA experiments, we assessed each method's ability to predict observed responses and the number of candidate HLAs it assigned. At matched specificity for predicting MIRA responses, HLAResolver achieved higher sensitivity while selecting fewer candidate HLAs per peptide than either comparator.
ER -